Markets:

Overview

News

Currencies

International

Treasuries

Maravai LifeSciences Holdings, Inc. - Class A common stock (NQ:MRVI)

7.175 -0.545 (-7.06%)

Delayed Quote Updated: 12:09 PM EST, Nov 5, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Maravai LifeSciences Holdings, Inc. - Class A common stock

< Previous 1 2

...

8 9 10 11 12 13 14 15 Next >

Analyst Ratings for Maravai LifeSciences ↗

November 03, 2022

Analysts have provided the following ratings for Maravai LifeSciences (NASDAQ:MRVI) within the last quarter:

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday ↗

November 03, 2022

We're starting off the day with a look at the latest news behind the biggest pre-market stock movers for Thursday morning!

Via InvestorPlace

Maravai LifeSciences Holdings, Inc. (MRVI) Q3 2022 Earnings Call Transcript ↗

November 03, 2022

MRVI earnings call for the period ending September 30, 2022.

Via The Motley Fool

Maravai LifeSciences Reports Third Quarter 2022 Financial Results

November 02, 2022

Updates Revenue, Adjusted EBITDA and Adjusted EPS Guidance for 2022

From Maravai LifeSciences Holdings LLC

Via GlobeNewswire

Stocks That Hit 52-Week Lows On Thursday ↗

October 20, 2022

Thursday saw 177 companies set new 52-week lows.

Via Benzinga

Stocks That Hit 52-Week Lows On Wednesday ↗

October 19, 2022

On Wednesday, 200 companies hit new 52-week lows.

Via Benzinga

Recap: Maravai LifeSciences Q2 Earnings ↗

August 04, 2022

Maravai LifeSciences (NASDAQ:MRVI) reported its Q2 earnings results on Thursday, August 4, 2022 at 04:00 PM. Here's what investors need to know about the announcement.

Via Benzinga

This Fallen Growth Stock Is Still a Wall Street Favorite: Here's Why ↗

October 29, 2022

It's positioned to benefit from the emergence of a new, long-term trend in biopharma.

Via The Motley Fool

Abbott Laboratories, M&T Bank And Some Other Big Stocks Moving Lower On Wednesday ↗

October 19, 2022

U.S. stocks traded higher, with the Dow Jones gaining more than 100 points on Wednesday. Here are some big stocks recording losses in today’s session.

Via Benzinga

Maravai LifeSciences Temporarily Reinstates Carl Hull as CEO Amidst Pending Noncompetition Litigation

October 19, 2022

Maravai LifeSciences and Recently-Appointed CEO Trey Martin Vigorously Defending Against Suit

From Maravai LifeSciences Holdings LLC

Via GlobeNewswire

Maravai LifeSciences To Host Earnings Conference Call on Wednesday, November 2, 2022

October 18, 2022

From Maravai LifeSciences Holdings LLC

Via GlobeNewswire

Why KalVista Pharmaceuticals Shares Are Trading Lower By 59%; Here Are 89 Biggest Movers From Yesterday ↗

October 05, 2022

Losers

Via Benzinga

Why AeroClean Technologies Shares Are Trading Higher By Around 38%, Here Are 58 Stocks Moving In Tuesday's Mid-Day Session ↗

October 04, 2022

Gainers Bit Brother Limited (NASDAQ: BTB) rose 229% to $0.3688 after declining around 14% on Monday.

Via Benzinga

Stocks That Hit 52-Week Lows On Tuesday ↗

October 04, 2022

On Tuesday, 44 companies hit new 52-week lows.

Via Benzinga

FaZe Holdings, AXT And Some Other Big Stocks Moving Lower On Tuesday ↗

October 04, 2022

U.S. stocks traded higher, with the Dow Jones gaining more than 700 points on Tuesday. Here are some big stocks recording losses in today’s session.

Via Benzinga

Maravai LifeSciences Announces CEO Leadership Transition

October 03, 2022

From Maravai LifeSciences Holdings LLC

Via GlobeNewswire

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

September 22, 2022

Gainers Genfit (NASDAQ:GNFT) shares increased by 27.4% to $5.12 during Thursday's after-market session. The market value of their outstanding shares is at $255.0 million.

Via Benzinga

Why Stabilis Solutions Shares Jumped Over 71%; Here Are 70 Biggest Movers From Yesterday ↗

September 22, 2022

Gainers

Via Benzinga

Stocks That Hit 52-Week Lows On Wednesday ↗

September 07, 2022

On Wednesday, 297 companies achieved new lows for the year.

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For August 25, 2022 ↗

August 25, 2022

Upgrades

Via Benzinga

Earnings Outlook For Maravai LifeSciences ↗

August 03, 2022

Maravai LifeSciences (NASDAQ:MRVI) is set to give its latest quarterly earnings report on Thursday, 2022-08-04. Here's what investors need to know before the announcement. Analysts estimate that...

Via Benzinga

5 Cheap Healthcare Stocks in 2022 ↗

July 21, 2022

Now, in the summer of 2022, healthcare stocks have been ignored and are cheap.

Via Talk Markets

Stocks That Hit 52-Week Lows On Friday ↗

July 15, 2022

On Friday, 137 stocks made new 52-week lows.

Via Benzinga

10 Health Care Stocks Whale Activity In Today's Session ↗

March 18, 2022

This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...

Via Benzinga

Sail Through the Choppy Market With These 4 Low-Beta Stocks ↗

March 05, 2022

Creating a portfolio of low-beta stocks is important since the securities can deliver healthy returns and provide a shield against volatile market conditions.

Via Talk Markets

Maravai LifeSciences Rejects Sartorius' $11B Takeover Bid: Reuters ↗

February 28, 2022

Germany-based laboratory equipment supplier Sartorius AG has approached Maravai LifeSciences Holdings Inc (NASDAQ: MRVI) with an $11 billion acquisition offer...

Via Benzinga

Maravai LifeSciences: Q4 Earnings Insights ↗

February 23, 2022

Maravai LifeSciences (NASDAQ:MRVI) reported its Q4 earnings results on Wednesday, February 23, 2022 at 04:00 PM. Here's what investors need to know about the announcement....

Via Benzinga

The Daily Biotech Pulse: Kodiak Sinks On Adverse Study Outcome, Marinus Flags Delay In Clinical Trial, Mainz Biomed Gains On Positive Regulatory Development ↗

February 23, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Kodiak's Wet AMD Treatment KSI-301 Did Not Meet Primary Endpoint In Phase...

Via Benzinga

Earnings Scheduled For February 23, 2022 ↗

February 23, 2022

Companies Reporting Before The Bell • Sapiens Intl Corp (NASDAQ:SPNS) is likely to report earnings for its fourth quarter. • Plymouth Industrial REIT (NYSE:PLYM)...

Via Benzinga

The Week Ahead In Biotech (Feb. 20-26): Reata Awaits FDA Decision, Bausch Health, Moderna Lead Earnings News Flow ↗

February 20, 2022

Biotech stock extended lower for a second straight week as risk aversion continued to pressure stocks amid geopolitical tensions and macroeconomic worries. On the regulatory front...

Via Benzinga

< Previous 1 2

...

8 9 10 11 12 13 14 15 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.